Congress funds diabetes care in underserved communities nationwide
H.R. 6241 — Urban and Rural Diabetes Initiative Act · Filed by Maxine Waters (D-CA) · 23 cosponsors · Introduced Nov 20, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill authorizes federal grants to public and nonprofit healthcare providers—including community health centers, rural clinics, and tribal health departments—to expand diabetes treatment and prevention services in underserved urban and rural areas. Grantees must provide routine diabetes care, eye and foot care, kidney disease treatment, patient education, and culturally appropriate outreach. Funding is authorized for fiscal years 2026–2031, with no specific dollar amount specified.
Why we flagged it
This bill establishes a federal grant program to fund diabetes treatment and prevention services in medically underserved urban and rural communities. It is a straightforward public health initiative with no hidden commercial provisions or narrow beneficiaries.
What the text implies
- Grant funding may indirectly increase demand for diabetes medications and diagnostic services, potentially benefiting pharmaceutical and medical device manufacturers, though this is a natural consequence of expanded care access rather than a hidden provision.
- The requirement for culturally and linguistically appropriate services may create operational costs for providers that could be passed through to payers or reduce provider margins if not adequately funded.
The full analysis lists 3 implications of this text.
Who stands to gain
pharmaceutical companies (diabetes medications); medical device manufacturers (glucose monitors, insulin pumps); healthcare providers and clinics